106 related articles for article (PubMed ID: 11365973)
1. New study of Fortovase (Saquinavir) in women.
WORLD; 1998 Nov; (No 91):4. PubMed ID: 11365973
[TBL] [Abstract][Full Text] [Related]
2. Do women respond differently to HIV therapy than men?
Newsline People AIDS Coalit N Y; 1998 Dec; ():31. PubMed ID: 11367087
[TBL] [Abstract][Full Text] [Related]
3. New formulation of saquinavir (Fortovase) is more effective.
Tam CW
Fac Notes (New Orleans La); 1998; 10(2):11. PubMed ID: 11365126
[TBL] [Abstract][Full Text] [Related]
4. Are men and women really different?
Res Initiat Treat Action; 1998 Dec; 4(7):13. PubMed ID: 11366080
[TBL] [Abstract][Full Text] [Related]
5. Goodbye, Invirase. Hello, Fortovase.
Vazquez E
Posit Aware; 1998; 9(1):45-6. PubMed ID: 11365001
[TBL] [Abstract][Full Text] [Related]
6. Anti-HIV agents. Saquinavir--switching from Fortovase to Invirase.
TreatmentUpdate; 2004; 16(3):8-9. PubMed ID: 17219608
[No Abstract] [Full Text] [Related]
7. Women's nelfinavir (Viracept) trial.
Vazquez E
Posit Aware; 1997; 8(5):15. PubMed ID: 11364633
[TBL] [Abstract][Full Text] [Related]
8. Saquinavir, the pioneer antiretroviral protease inhibitor.
la Porte CJ
Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1313-22. PubMed ID: 19737048
[TBL] [Abstract][Full Text] [Related]
9. Saquinavir (Fortovase or Invirase).
Res Initiat Treat Action; 2000 Mar; 6(1):24-5. PubMed ID: 11708182
[No Abstract] [Full Text] [Related]
10. Study to address effects of antiretroviral therapy on women.
Hanna L
BETA; 1999 Apr; 12(2):16. PubMed ID: 11366677
[TBL] [Abstract][Full Text] [Related]
11. [Good experiences with saquinavir. Double boosting of protease inhibitors gains significance].
MMW Fortschr Med; 2004 Apr; 146 Spec No 1():44. PubMed ID: 15373047
[No Abstract] [Full Text] [Related]
12. Fortovase approved: new saquinavir formulation.
James JS
AIDS Treat News; 1997 Nov; (No 283):1. PubMed ID: 11364907
[TBL] [Abstract][Full Text] [Related]
13. Saquinavir/low-dose ritonavir: its use in HIV infection.
Johnson M; Peters B
AIDS Rev; 2003; 5(1):44-51. PubMed ID: 12875107
[TBL] [Abstract][Full Text] [Related]
14. Saquinavir (Invirase): first protease inhibitor approved--reimbursement, information hotline numbers.
James JS
AIDS Treat News; 1995 Dec; (no 237):1-2. PubMed ID: 11363073
[TBL] [Abstract][Full Text] [Related]
15. Saquinavir as Fortovase: why does it matter?
Trapnell CB
AIDS Clin Care; 1998 May; 10(5):37, 40. PubMed ID: 11365428
[TBL] [Abstract][Full Text] [Related]
16. Anti-HIV agents. A protease-only regimen--Kaletra and saquinavir.
TreatmentUpdate; 2004; 16(3):8. PubMed ID: 17216837
[No Abstract] [Full Text] [Related]
17. Saquinavir (Roche protease inhibitor) at higher doses.
AIDS Treat News; 1995 Sep; (no 231):5. PubMed ID: 11362870
[TBL] [Abstract][Full Text] [Related]
18. What they say about protease inhibitors.
Posit Aware; 1999; 10(1):38-43. PubMed ID: 11366522
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of twice-daily versus three-times daily saquinavir soft gelatin capsules as part of triple combination therapy for HIV-1 infection.
Wheat LJ; Farthing C; Cohen C; Pierone G; Lalezari J; Pilson RS; Siemon-Hryczyk P;
Antivir Ther; 2002 Sep; 7(3):199-209. PubMed ID: 12487388
[TBL] [Abstract][Full Text] [Related]
20. Saquinavir/Ritonavir: its evolution and current treatment role.
O'Brien WA
AIDS Read; 2006 Jan; 16(1):38-44; discussion 43. PubMed ID: 16433471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
